Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Hepatocellular × Doxorubicin × Clear all

Phase

Phase 2 15 Phase 3 12 Phase NA 4 Phase 1/2 4 Phase 1 4 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Breast Neoplasms 3 Neoplasm, Residual 2 Wilms Tumor 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Rhabdomyosarcoma 1 Obesity 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Liver Neoplasms 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Body Weight 1

Interventions

Sorafenib 8 gadolinium ethoxybenzyl DTPA 4 Hepatectomy 4 lenvatinib 3 Sufentanil 3 Ribavirin 3 Propranolol 3 sofosbuvir-velpatasvir drug combination 2 peginterferon alfa-2a 2 gadoterate meglumine 2 entecavir 2 Thrombectomy 2 Tenofovir 2 Sevoflurane 2 Lamivudine 2 Esketamine 2 Chemoembolization, Therapeutic 2 xihuang 1 stronger neominophagen C 1 ledipasvir 1 huaier 1 gadoteridol 1 gadodiamide 1 gadobutrol 1 gadobenic acid 1 flurbiprofen axetil 1 fish oil triglycerides 1 contrast agent BR1 1 chlorhexidine gluconate 1 cantharidin methylimide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00936689 2012-12-24

PRECISION-IT

University of Bologna

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡